Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.4 NOK
45.60 M NOK
435.39 M NOK
20.39 M
About VISTIN PHARMA ASA
Sector
CEO
Magnus Tolleshaug
Headquarters
Oslo
Website
Founded
2015
ISIN
NO0010734122
FIGI
BBG00N0NSXY8
Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). It offers Metformin HCI and Metformin DC. The company was founded on March 6, 2015 and is headquartered in Oslo, Norway.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VISTNO is 24.0 NOK — it has increased by 12.68% in the past 24 hours. Watch VISTIN PHARMA ASA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange VISTIN PHARMA ASA stocks are traded under the ticker VISTNO.
VISTNO reached its all-time high on Jun 15, 2023 with the price of 24.8 NOK, and its all-time low was 17.0 NOK and was reached on Dec 1, 2020. View more price dynamics on VISTNO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VISTNO stock is 11.25% volatile and has beta coefficient of −0.14. Track VISTIN PHARMA ASA stock price on the chart and check out the list of the most volatile stocks — is VISTIN PHARMA ASA there?
Today VISTIN PHARMA ASA has the market capitalization of 1.13 B, it has increased by 3.90% over the last week.
Yes, you can track VISTIN PHARMA ASA financials in yearly and quarterly reports right on TradingView.
VISTIN PHARMA ASA is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
VISTNO net income for the last quarter is 16.57 M NOK, while the quarter before that showed 19.16 M NOK of net income which accounts for −13.55% change. Track more VISTIN PHARMA ASA financial stats to get the full picture.
As of Nov 10, 2024, the company has 77.00 employees. See our rating of the largest employees — is VISTIN PHARMA ASA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VISTIN PHARMA ASA EBITDA is 101.61 M NOK, and current EBITDA margin is 19.06%. See more stats in VISTIN PHARMA ASA financial statements.
Like other stocks, VISTNO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VISTIN PHARMA ASA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VISTIN PHARMA ASA technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VISTIN PHARMA ASA stock shows the strong buy signal. See more of VISTIN PHARMA ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.